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Abstract
Introduction: Clinical laboratories offer several multipurpose tests, such as the erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP), which are not intended to diagnose any specific disease but are used
by clinicians in multiple fields. The results and laboratory interpretation (normal/abnormal) of these
multipurpose tests are based on laboratory-reported normal thresholds, which vary across clinical
laboratories. In 2018, the International Consensus Meeting on Musculoskeletal Infection (2018 ICM)
provided a gold-standard definition to diagnose periprosthetic joint infection (PJI) which included many
multipurpose laboratory tests, along with thresholds optimized to diagnose PJI. The discrepancy between
laboratory-reported normal thresholds and 2018 ICM-recommended PJI-optimized test thresholds has never
been studied. The purpose of this study was to assess the existing variation in laboratory-reported normal
thresholds for tests commonly used to diagnose PJI and evaluate the potential diagnostic impact of using
laboratory-reported normal thresholds instead of 2018 ICM-recommended PJI-optimized thresholds.
Methods: Clinical laboratories (N=85) were surveyed to determine the laboratory-reported units of measure
and normal thresholds for common multipurpose tests to diagnose PJI, including the ESR, CRP, D-dimer,
synovial fluid white blood cells (SF-WBC), and polymorphonuclear cell percent (SF-PMN%). The variability
of units of measure and normal thresholds for each test was then assessed among the 85 included clinical
laboratories. A representative dataset from patients awaiting a revision arthroplasty was used to determine
the clinical significance of the existing discrepancy between laboratory-reported normal test interpretations
and 2018 ICM-recommended PJI-optimized test interpretations.
Results: Two units of measure for the CRP and six units of measure for the D-dimer were observed, with only
59% of laboratories reporting the CRP in terms of mg/L and only 16% reporting the D-dimer in ng/ml, as
needed to utilize the 2018 ICM definition of PJI. Across clinical laboratories surveyed, the mean laboratoryreported normal thresholds for the ESR (20 mm/h), CRP (7.69 mg/L), D-dimer (500 ng/mL), SF-WBC (5
cells/uL), and SF-PMN% (25%) were substantially lower than the 2018 ICM-recommended PJI-optimized
thresholds of 30 mm/h, 10 mg/L, 860 ng/mL, 3,000 cells/uL, and 70%, respectively. Interpretation of test
results from a representative PJI dataset using each laboratory’s normal test thresholds yielded mean falsepositive rates of 14% (ESR), 18% (CRP), 42% (D-dimer), 93% (SF-WBC), and 36% (SF-PMN%) versus the ICMrecommended PJI-optimized thresholds.
Conclusion: When reporting the results for multipurpose laboratory tests, such as the ESR, CRP, D-dimer,
SF-WBC, and SF-PMN%, clinical laboratories utilize laboratory-reported units of measure and normal
thresholds that are not intended to diagnose PJI, and therefore may not match the 2018 ICM
recommendations. Our findings reveal that laboratory-reported normal thresholds for these multipurpose
tests are well below the 2018 ICM recommendations to diagnose PJI. Clinical reliance on laboratory-reported
results and interpretations, instead of strict use of the 2018 ICM-recommended units and PJI-optimized
thresholds, may lead to false-positive interpretation of multipurpose laboratory tests.

Categories: Infectious Disease, Orthopedics
Keywords: infection, tha, tka, laboratory, diagnosis, pji

Introduction
Physicians diagnosing periprosthetic joint infection (PJI) have historically had a variety of diagnostic tools at
their disposal, with a recent move in the field away from complete reliance on cultures toward a
multicriteria definition of PJI. Multicriteria tools such as the 2013 and 2018 International Consensus
Meeting (ICM) definitions of PJI require the use of several laboratory tests, many of which are considered
multipurpose laboratory tests [1,2]. These multipurpose tests include the erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), D-dimer, synovial fluid white blood cell count (SF-WBC), and
polymorphonuclear cell percentage (SF-PMN%). Although laboratories provide their own laboratory-
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reported normal threshold ranges for each laboratory test, authoritative bodies such as the ICM recommend
PJI-optimized thresholds which are intended to override the laboratory-reported normal thresholds for PJI
test interpretation. Using these PJI-optimized thresholds, instead of the standard laboratory reference
thresholds, is required to appropriately utilize these multiple-criteria diagnostic tools [2].
Laboratories are required to establish a normal reference interval for each test, which is defined as the
central 95% of values expected from a healthy local population [3]. This requirement exists to properly
account for demographic differences in local populations, such as age, diet, altitude, etc. In many cases, this
range can be transferred from the test’s manufacturer with appropriate local verification, while in other
cases, a laboratory may create a new normal reference range through testing a minimum of 120 local healthy
sample donors [3]. The reference range should not be confused with test result bias, which describes the
small differences in results that may be observed at different laboratories analyzing the same samples [3].
For the purposes of this study, it is important to understand that normal reference ranges may vary by
laboratory, and the procedures required to set these reference ranges do not involve the diagnosis of PJI and
cannot be interpreted and having any meaningful application to the diagnosis of PJI.
Differences between laboratory-reported normal thresholds and PJI-optimized thresholds may be critically
important, as they would produce different sensitivity and specificity performance for each test, and impact
the diagnostic accuracy of each test for PJI [4]. Although never studied or quantified in the literature, the use
of laboratory-reported normal thresholds by clinicians evaluating a patient for PJI is commonplace in
orthopedics. In fact, even recent continuing medical education materials from the American Academy of
Orthopaedic Surgeons (AAOS) provide the laboratory-reported normal threshold range for test results in
their questions, implying the importance of the laboratory-reported normal threshold in diagnosing PJI
[5,6]. Given the ever-changing recommendations of PJI-optimized test thresholds, over time [7,8], between
institutions [9,10], and between authoritative bodies and PJI definitions [1,2,11], the widespread adoption
and correct use of PJI-optimized laboratory thresholds, instead of laboratory-reported reference thresholds,
may not be a realistic expectation. It is reasonable to expect that clinicians unfamiliar with PJI-optimized
cutoffs may use laboratory-reported normal thresholds in routine clinical practice for diagnostic decisionmaking.
Although the complexity of utilizing alternative PJI-optimized test thresholds may be avoided by relying on
laboratory-reported normal thresholds, the potential diagnostic impact of this practice has never been
evaluated in the literature. The purpose of this study was to assess the existing variation in the laboratoryreported normal thresholds for common PJI tests across a sampling of clinical laboratories and evaluate the
potential diagnostic impact of using laboratory-reported normal thresholds instead of ICM-recommended
PJI-optimized thresholds.

Materials And Methods
This study was determined to be exempt from institutional review board approval (WCG Institutional Review
Board). An earlier version of this study was presented as an abstract on August 7, 2020, at the
Musculoskeletal Infection Society Meeting.

Laboratories surveyed
A total of 85 clinical laboratories were contacted by the authors of this study. The sampling of hospitals in
this study was determined by the availability of contact at the hospital or laboratory through an author in the
study, and an effort to include a combination of both community hospitals and academic centers. This study
included laboratories from 18 states in the United States (US), and comprised 41 academic center hospital
laboratories and 44 community hospital laboratories, with 85% (70/85) located in the northeast, US. All
clinical laboratories in this study were contacted and surveyed by the authors (SF, JD, ZW) to determine
standard reporting practices for each test. The following clinical laboratory tests were included in this study:
the ESR, CRP, D-dimer, SF-WBC, and SF-PMN%. Both the units of measure and the normal threshold
determining the laboratory-reported interpretation for each test were recorded. The number of clinical
laboratories that provided a normal threshold for each test was 85 of 85 for ESR, 80 of 85 for CRP, 82 of 85
for d-dimer, 77 of 85 for SF-WBC, and 16 of 85 for SF-PMN%. Some laboratories were unable to provide a
normal threshold for all tests because they either do not offer the test or do not report a single normal range
associated with the test.

Data and analysis
The variability in the clinical laboratory-reported units of measure was assessed for each laboratory test
across all clinical laboratories. The variability across clinical laboratories of the laboratory-reported normal
threshold for test reporting was also assessed. For each test with variations in units across laboratories, all
laboratory reference thresholds reported were unit-adjusted using a conversion table to allow for appropriate
relative comparisons of laboratory-reported normal thresholds between the 85 laboratories (Table 1).
Descriptive statistics were used to describe the range of reference thresholds reported by laboratories in this
study.
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Test

Laboratory reported units

Conversion factor

2018 ICM unit usage

mg/L

×1

mg/L

mg/dL

×10

mg/L

ng/mL FEU

×1

ng/mL

ug/mL FEU

×1000

ng/mL

ug/L FEU

×1

ng/mL

mg/L FEU

×1000

ng/mL

ng/ml DDU

×2

ng/mL

mg/L DDU

×2000

ng/mL

CRP

D-dimer

TABLE 1: Conversion of laboratory reported units to 2018 ICM units
ICM: International Consensus Meeting; CRP: C-reactive protein; FEU: fibrinogen equivalent units; DDU: D-dimer units

The potential clinical impact of the observed variations in laboratory-reported normal test interpretations
was then evaluated. We used a representative deidentified clinical dataset of existing laboratory values (ESR,
CRP, D-dimer, SF-WBC, SF-PMN%) from previous PJI studies, which is representative of laboratory value
distributions observed in the clinical practice of evaluating painful arthroplasties for PJI [12,13]. This clinical
dataset of representative raw laboratory values was then subjected to interpretation (normal, high,
abnormal, etc) by each laboratory’s normal thresholds, so that each of the 85 laboratories’ standard
reference reporting practices was applied to the same representative clinical dataset of laboratory values.
The standard diagnostic reporting performance of each clinical laboratory, for each test, was then compared
to a gold standard reporting performance that was determined by applying the 2018 ICM-recommended PJIspecific thresholds to the representative clinical dataset (Table 2) [2]. For example, if the laboratoryreported normal threshold reported a CRP of 8 mg/L as “high”, this would be considered a false-positive
result compared to the 2018 ICM-recommended PJI-optimized threshold of 10 mg/L.

Multipurpose tests

PJI-optimized threshold

Units

ESR

30

mm/h

CRP

10

mg/L

D-dimer

860

ng FEU/mL

SF-WBC

3000

cells/uL

SF-PMN%

70

%

TABLE 2: 2018 ICM-recommended PJI-optimized test thresholds for chronic PJI
ICM: International Consensus Meeting; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SF-WBC: synovial fluid white blood cells; SFPMN%: synovial fluid polymorphonuclear cell percentage; FEU: fibrinogen equivalent units

The laboratory-reported normal thresholds were generally lower than the 2018 ICM-recommended PJIoptimized threshold, resulting in laboratory-reported interpretations that were false-positive compared to
an interpretation using 2018 ICM thresholds. The mean false-positive interpretation rate was calculated for
each test across all laboratories and considered clinically significant when greater than 10% of any test’s
reported results were categorized as false-positive compared to the ICM standard.

Results
Units of measure
The ESR (mm/h), SF-WBC (cell/uL), and SF-PMN% (%) were reported in 2018 ICM-recommended units of
measure across all laboratories. In contrast, laboratories variably reported the CRP in a total of two different
units of measure (mg/L and mg/dL) and the D-dimer in a total of six different units of measure (ng/mL FEU,
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ug/mL FEU, ug/L FEU, mg/L FEU, ng/mL DDU, mg/L DDU). Only 59% of laboratories reported the CRP in
terms of mg/L and only 16% reported the D-dimer in ng/mL FEU, the respective units required to utilize the
2018 ICM (Table 3).

Test

Laboratory-reported units

Clinical laboratory unit usage rate

2018 ICM unit usage

ESR

mm/h

85/85 (100%)

mm/h

mg/L

47/80 (59%)

mg/L

mg/dL

33/80 (41%)

mg/L

ng/mL FEU

13/82 (16%)

ng/mL

ug/mL FEU

32/82 (39%)

ng/mL

ug/L FEU

2/82 (2%)

ng/mL

mg/L FEU

20/82 (24%)

ng/mL

ng/mL DDU

13/82 (16%)

ng/mL

mg/L DDU

1/82 (1%)

ng/mL

SF-WBC

cells/uL

77/77 (100%)

cells/uL

SF-PMN%

%

16/16 (100%)

%

CRP

D-dimer

TABLE 3: Laboratory-reported usage of units of measure
ICM: International Consensus Meeting; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SF-WBC: synovial fluid white blood cells; SFPMN%: synovial fluid polymorphonuclear cell percentage; FEU: fibrinogen equivalent units; DDU: D-dimer units

Laboratory-reported normal test thresholds
The laboratory-reported normal thresholds, to report a test as normal or abnormal to the ordering physician,
exhibited variability and differed substantially from the 2018 ICM-recommended PJI-optimized threshold for
each test in this study. The median laboratory-reported normal thresholds for the ESR, CRP, D-dimer, SFWBC, and SF-PMN% across laboratories in this study were 20 mm/h, 7.7 mg/L, 500 ng/mL, 5 cells/uL, and
25%, which are 33%, 23%, 42%, 99%, and 69% lower than the 2018 ICM-recommended PJI-optimized
thresholds, respectively (Table 4).

Percent of clinical

Minimum laboratory-

Maximum laboratory-

Median laboratory-

2018 ICM PJI-

laboratories reporting

reported reference

reported reference

reported reference

optimized

standard threshold

threshold

threshold

threshold

threshold

ESR (mm/h)

100% (85/85)

10 mm/h

53 mm/h

20 mm/h

30 mm/h

CRP (mg/L)

94% (80/85)

2.9 mg/L

20mg/L

7.7 mg/L

10 mg/L

96% (82/85)

400 ng/mL FEU

1000 ng/mL FEU

500 ng/mL FEU

860 ng/mL

90% (77/85)

0 cells/uL

499 cells/uL

5 cells/uL

3000 cells/uL

18% (16/85)

24%

25%

25%

70%

Multipurpose
tests

D-dimer
(ng/mL FEU)
SF-WBC
(cells/uL)
SF-PMN%

TABLE 4: Descriptive analysis of laboratory-reported normal thresholds versus 2018 ICMrecommended thresholds
ICM: International Consensus Meeting; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SF-WBC: synovial fluid white blood cells; SFPMN%: synovial fluid polymorphonuclear cell percentage; FEU: fibrinogen equivalent units

Clinical impact of using laboratory-reported normal test interpretations
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Among laboratory results from a cohort of patients being tested for PJI, a substantial proportion of testing
results would be laboratory reported as “high/abnormal,” despite being below the 2018 ICM threshold and
“negative” for PJI. When compared to the 2018 ICM-recommended PJI-optimized thresholds, laboratoryreported normal thresholds resulted in mean false-positive test rates of 14%,18%, 42%, 93%, and 36% for the
ESR, CRP, D-dimer, SF-WBC, and SF-PMN%, respectively, for the diagnosis of PJI across laboratories
included in this study. The observed mean false-positive rate of laboratory-reported threshold
interpretations relative to 2018 ICM-recommended threshold interpretations was clinically significant
(>10%) for all laboratory tests considered (Table 5).

Median laboratory-

2018 ICM PJI-

Mean laboratory

Minimum laboratory

Maximum laboratory

reported standard

optimized

threshold false-

threshold false-positive

threshold false-positive

threshold

threshold

positive rate

rate

rate

ESR

20 mm/h

30 mm/h

14% (28/197)

0% (0/197)

37% (73/197)

CRP

7.69 mg/L

10 mg/L

18% (32/176)

0% (0/176)

61% (108/176)

D-dimer

500 ng/mL

860 ng/mL

42% (39/94)

0% (0/94)

65% (61/94)

SF-WBC

5 cells/uL

3000 cells/uL

93% (213/229)

0% (0/229)

100% (228/229)

SF-PMN%

25%

70%

36% (78/216)

36% (78/216)

36% (78/216)

Multipurpose
tests

TABLE 5: False-positive rates of utilizing laboratory reported reference thresholds instead of ICM
recommended thresholds
ICM: International Consensus Meeting; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SF-WBC: synovial fluid white blood cells; SFPMN%: synovial fluid polymorphonuclear cell percentage; FEU: fibrinogen equivalent units

Discussion
The proper interpretation of laboratory test results is critical for optimal implementation of a multiplecriterion diagnostic tool such as the 2018 ICM definition of PJI. Unfortunately, the laboratory-reported
normal test thresholds from clinical laboratories are not intended to diagnose PJI and do not match 2018 ICM
recommendations [2]. This study is the first, to our knowledge, to evaluate the discrepancy between the
laboratory-reported normal thresholds and ICM-recommended PJI-optimized test thresholds and to assess
the potential clinical consequence of clinician reliance on the laboratory-reported normal interpretations of
these tests.
This study has identified several pragmatic concerns related to the clinical practice of diagnosing PJI using
multiple-criterion tools. First, the CRP and D-dimer, two basic elements of the 2018 ICM definition of PJI,
are reported by US clinical laboratories in varying units of measure. In fact, 41% of clinical laboratories
reporting CRP results and 84% of clinical laboratories reporting D-dimer results utilize units of measure that
differ from the thresholds referenced by the 2018 ICM. The consequence of this reporting difference is the
requirement that the ordering clinician converts the result to appropriate units to allow for proper test
interpretation using the 2018 ICM-recommended PJI-optimized thresholds. While this conversion may seem
simple to those in academic medicine, we believe it likely that many practicing clinicians are failing to make
the appropriate conversion in daily clinical practice, and instead rely on the laboratory-reported normal
reference test interpretation, leading to suboptimal implementation of the ICM tool. In fact, a recent study
in the coronavirus literature expressed a similar concern, having identified existing confusion and errors
even in the peer-reviewed literature regarding the reporting and interpretation of D-dimer results [14].
Further research is needed to identify what percentage of clinicians are successfully making the units of
conversion, and whether or not this difficulty in unit conversion adversely affects the clinical adoption and
performance of multiple-criterion tools by physicians.
Secondly, this study demonstrates a large discrepancy between the laboratory-reported normal test
thresholds and those recommended by the 2018 ICM, which is a consequence of the fact that these tests are
multipurpose tests that were never designed or optimized by the laboratory to diagnose PJI [2]. Every test
assessed in this study, including the ESR, CRP, D-dimer, SF-WBC, and SF-PMN%, had a mean laboratoryreported normal threshold across clinical laboratories that demonstrated a substantial difference from the
2018 ICM recommendations, being set far below the test thresholds that have been recommended as optimal
to diagnose PJI by the 2018 ICM [2]. We further demonstrated that a large percentage of laboratory results,
from a representative PJI patient sample set, fall into the discrepancy gap between the laboratory-reported
normal thresholds and the 2018 ICM-recommended PJI-optimized thresholds for all tests, resulting in the
potential for false-positive interpretations if the clinician relies on the laboratory-reported normal test
interpretation. Most concerning was the laboratory-reported interpretation of serum CRP results, a
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universally utilized test for PJI, which demonstrated a mean 18% false-positive “high or abnormal”
interpretation rate when compared to the ICM-recommended PJI-optimized interpretation. A false-positive
interpretation of laboratory values could move a patient into the infected category of the 2018 ICM PJI
diagnostic criteria, biasing a surgeon inappropriately toward surgical options and prolonged antibiotics that
may not be necessary.
This study’s finding, that there is a clinically important discordance between laboratory-reported test
interpretations and those recommended by the 2018 ICM to diagnose PJI, suggests that it is important and
impactful for clinicians to ignore the laboratory-reported normal test interpretation from the clinical
laboratory, and instead convert to appropriate units of measure and apply the 2018 ICM-recommended PJIoptimized threshold. While using the 2018 ICM-recommended PJI-optimized threshold for a multipurpose or
off-label test may seem a simple task to academic surgeons who perform PJI research, it exists as a potential
barrier to widespread appropriate clinical adoption of the 2018 ICM tool and a source of potential error
during its clinical use [15,16]. Complexity and the need to execute multiple rules are known barriers to
guideline compliance among clinicians, as tasks that seem straightforward to experienced clinicians may
cause confusion among less experienced clinicians [16,17]. While there is little PJI research assessing the
appropriate implementation of multiple-criterion diagnostic tools by practicing physicians, a recent
study demonstrates poor inter-physician agreement even when physicians are directed to use a specific
multiple-criterion tool to diagnose PJI [18]. Our study’s findings of discordance between laboratory-reported
and ICM-recommended test interpretations offer one rationale explaining inconsistency in implementation
of a multiple-criterion tool to diagnose PJI.

Limitations
This study only involves laboratories in the US but did not include all US laboratories. This weakness is
mitigated by the fact that 85 laboratories were included, and a relatively even distribution of academic and
community hospitals was chosen to provide some diversity of laboratories across 18 states. It is always
possible that the subset of laboratories chosen introduced bias, although the observed variabilities in testing
units and laboratory-reported normal thresholds would still remain concerning. Additionally, the
presumption of this study is that some clinicians utilize laboratory-reported normal thresholds and
interpretations instead of 2018 ICM recommended thresholds. Although this presumption is not supported
by any existing literature, as there has never been a study evaluating this specific practice, the authors of
this study believe that this presumption is reasonably obvious in daily practice, as colleagues routinely use
laboratory-reported results (normal/abnormal) in decision-making to diagnose PJI. This is especially
observable in routine practice interpreting CRP and D-dimer results, which have various units of measure
and laboratory-reported normal thresholds across laboratories.

Conclusions
The first conclusion of this study is that clinical laboratories exhibit variable reporting of both the units and
standard thresholds for the multipurpose tests used to diagnose PJI. Although laboratories demonstrated
consistency in the units used to report the results of the ESR (mm/h), SF-WBC (cells/uL), and SF-PMN% (%),
variability in units usage was observed in the reporting of the CRP and D-dimer result, with D-dimer results
reported in a total of six different units of measure. In addition to reporting variable units of measure,
laboratories exhibited variable normal thresholds utilized to report a test as normal versus abnormal. In
general, clinical laboratories used normal reporting thresholds that were below the 2018 ICM-recommended
thresholds to optimally diagnose PJI.
The second conclusion of this study is that the differences between laboratory-reported normal thresholds
and 2018 ICM-recommended thresholds for PJI are clinically significant, as clinician usage of the standard
laboratory interpretation, instead of the ICM-recommended interpretation, would have resulted in greater
than a 10% false-positive interpretation rate for all laboratory tests studied. Therefore, clinicians who utilize
laboratory-reported results (normal/abnormal), instead of applying the 2018 ICM recommendations, are at
risk of misinterpreting the tests routinely used to diagnose PJI.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. WCG Institutional
Review Board issued approval WIRB Work Order # 1-1310346-1. Subject: IRB exemption—regulatory opinion
Investigator: Carl Deirmengian, MD Protocol Title: Physician agreement in diagnosing periprosthetic joint
infection based on laboratory values This is in response to your request for an exempt status determination
for the above-referenced protocol. Western Institutional Review Board’s (WIRB’s) IRB Affairs department
reviewed the study under the Common Rule and applicable guidance. We believe the study is exempt under
45 CFR § 46.104(d)(2), because the research only includes interactions involving educational tests, survey
procedures, interview procedures, or observations of public behavior; and any disclosure of the human
subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil
liability or be damaging to the subjects’ financial standing, employability, educational advancement, or
reputation. This exemption determination can apply to multiple sites, but it does not apply to any
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institution that has an institutional policy of requiring an entity other than WIRB (such as an internal IRB)
to make exemption determinations. WIRB cannot provide an exemption that overrides the jurisdiction of a
local IRB or other institutional mechanism for determining exemptions. You are responsible for ensuring
that each site to which this exemption applies can and will accept WIRB’s exemption decision. Please note
that any future changes to the project may affect its exempt status, and you may want to contact WIRB about
the effect these changes may have on the exemption status before implementing them. WIRB does not
impose an expiration date on its IRB exemption determinations. If you have any questions, or if we can be of
further assistance, please contact Bridget D. Brave, JD, at 360-252-2466, or e-mail
regulatoryaffairs@wirb.com. Animal subjects: All authors have confirmed that this study did not involve
animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all
authors declare the following: Payment/services info: All authors have declared that no financial support
was received from any organization for the submitted work. Financial relationships: Levine declare(s)
stock/stock options from Exactech. Deirmengian declare(s) stock/stock options from Forcast, Trice, and
Biostar Ventures. Levine declare(s) personal fees from Link and Exactech. Levine declare(s) royalties from
Kluwer-Wolters (Publishing company) and Slack (Publishing Company). Levine declare(s) non-financial
support from AAHKS Patient Education Committee, Journal Of Arthroplasty, Orthopedics, and JBJS CME
Editor. Deirmengian declare(s) a grant and personal fees from Zimmer Biomet. This grant was not for this
study. Intellectual property info: Deirmengian has several patents in the the field of diagnostics,
specifically for the use of biomarkers to diagnose Infection. Other relationships: All authors have declared
that there are no other relationships or activities that could appear to have influenced the submitted work.
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